The role of dopamine in the brain -lessons learned from Parkinson's disease, NeuroImage, vol.190, pp.79-93, 2018. ,
Single quantum dot imaging reveals PKC?-dependent alterations in membrane diffusion and clustering of an attention-deficit hyperactivity disorder / autism / bipolar disorder-associated dopamine transporter variant, ACS Chem Neurosci, vol.10, pp.460-71, 2019. ,
Dopamine receptor mapping with PET imaging in Parkinson's disease, J Neurol, vol.261, pp.2251-63, 2014. ,
Dopa decarboxylase activity of the living human brain, Proc Natl Acad Sci, vol.88, pp.2721-2726, 1991. ,
Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease, Eur J Nucl Med Mol Imaging, vol.33, pp.200-209, 2006. ,
In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease, Ann Neurol, vol.47, pp.493-503, 2000. ,
Dopaminergic function and dopamine transporter binding assessed with positron emission tomography in Parkinson disease, Arch Neurol, vol.59, pp.580-586, 2002. ,
Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson's disease, Ann Neurol, vol.63, pp.388-94, 2008. ,
In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with 18F-AV-133, J Nucl Med, vol.51, pp.223-231, 2010. ,
Diagnostic accuracy of imaging brain vesicular monoamine transporter type 2 (VMAT2) in clinically uncertain parkinsonian syndrome (CUPS): a 3-year follow-up study in community patients, BMJ Open, vol.8, p.25533, 2018. ,
11C-PE2I and 18F-Dopa PET for assessing progression rate in Parkinson's: a longitudinal study, Mov Dis, vol.33, pp.117-144, 2018. ,
The role of 18F-FP-CIT PET in differentiation of progressive supranuclear palsy and frontotemporal dementia in the early stage, Eur J Nucl Med Mol Imaging, vol.45, pp.1585-95, 2018. ,
Presynaptic regulation of dopamine release: Role of the DAT and VMAT2 transporters, Neurochem Int, vol.122, pp.94-105, 2019. ,
, Brooks DJ Molecular imaging of dopamine transporter, Aging Res Rev, vol.30, pp.114-135, 2016.
Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease, Proc Natl Acad Sci, vol.90, pp.11965-11974, 1993. ,
High-affinity binding of [125I]RTI-55 to dopamine and serotonin transporters in rat brain, Synapse, vol.12, pp.27-36, 1992. ,
Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjects, J Cereb Blood Flow Metab, vol.14, pp.982-94, 1994. ,
Synthesis and ligand binding of nortropane derivatives: N-substituted 2?-Carbomethoxy-3?-(4 ? -iodophenyl)nortropane and N-(3-Iodoprop-(2E)-enyl)-2?-carbomethoxy-3?-(3 ? ,4 ? -disubstituted phenyl)nortropane. New high-affinity and selective compounds for the dopamine transporter, J Med Chem, vol.40, pp.1366-72, 1997. ,
Pharmacological characterization of (E)-N-(3-iodoprop-2-enyl)-2?-Carbomethoxy-3?-(4 ? -methylphenyl)nortropane as a selective and potent inhibitor of the neuronal dopamine transporter, J Pharmacol Exp Ther, vol.291, pp.648-54, 1999. ,
PE2I: a radiopharmaceutical for in vivo exploration of the dopamine transporter, CNS Neurosci Ther, vol.14, pp.47-64, 2008. ,
Predictive value of dopamine SPECT imaging with [ 123 I]PE2I in patients with subtle parkinsonian symptoms, Eur J Nucl Med Mol Imaging, vol.39, pp.242-50, 2012. ,
Use of [ 11 C]PE2I PET in differential diagnosis of Parkinsonian disorders, J Nucl Med, vol.56, pp.234-276, 2015. ,
Increase in thalamic binding of [ 11 C]PE2I in patients with schizophrenia: a positron emission tomography study of dopamine transporter, J Psychiatr Res, vol.43, pp.1219-1242, 2009. ,
Striatal and extrastriatal dopamine transporter availability in schizophrenia and its clinical correlates: a voxel-based and high-resolution PET study, vol.43, pp.1134-1176, 2017. ,
Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity, Biol Psychiatry, vol.57, pp.229-267, 2005. ,
Dopamine transporter and reward anticipation in a dimensional perspective: a multimodal brain imaging study, Neuropsychopharmacology, vol.43, pp.820-827, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01576551
Pharmacological characterization of (E)-N-(4-fluorobut-2-enyl)-2beta-carbomethoxy-3beta-(4'-tolyl)nortropane (LBT-999) as a highly promising fluorinated ligand for the dopamine transporter, J Pharmacol Exp Ther, vol.317, pp.147-52, 2006. ,
Synthesis, radiosynthesis and in vivo preliminary evaluation of [ 11 C]LBT-999, a selective radioligand for the visualization of the dopamine transporter with PET, Bioorg Med Chem, vol.14, pp.1115-1140, 2006. ,
Radiosynthesis of [ 18 F]LBT-999, a selective radioligand for the visualization of the dopamine transporter with PET, J. Labelled Compd Rad, vol.49, pp.687-98, 2006. ,
One-step radiosynthesis of [ 18 F]LBT-999: a selective radioligand for the visualization of the dopamine transporter with PET, J. Labelled Compd Rad, vol.50, pp.716-739, 2007. ,
Exploration of the Dopamine Transporter: in vitro and in vivo characterization of a high-affinity and high-specificity iodinated tropane Derivative (E)-N-(3-iodoprop-2-enyl)-2?-carbomethoxy-3?-(4 ? -methylphenyl) nortropane (PE2I), Nucl Med Biol, vol.25, pp.331-338, 1998. ,
Imaging of the striatal and extrastriatal dopamine transporter with 18F-LBT-999: quantification, biodistribution, and radiation dosimetry in nonhuman primates, J Nucl Med, vol.52, pp.1313-1334, 2011. ,
In vivo PET quantification of the dopamine transporter in rat brain with [ 18 F]LBT-999, Nucl Med Biol, vol.41, pp.106-119, 2014. ,
Extensive exploration of a novel rat model of Parkinson's disease using partial 6-hydroxydopamine lesion of dopaminergic neurons suggests new therapeutic approaches, Synapse, vol.73, p.22077, 2018. ,
Assessment of the protection of dopaminergic neurons by an alpha7 nicotinic receptor agonist, PHA 543613 using [(18)F]LBT-999 in a Parkinson's disease rat model, Front Med, vol.2, p.61, 2015. ,
Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson's disease, Cell Stem Cell, vol.15, pp.653-65, 2014. ,
PET imaging of Dopamine Transporter with 18F-LBT999: first human exploration, J Nucl Med, vol.58, p.276, 2017. ,
A simplified method for the diagnosis of striatal dopaminergic dysfunction using PET with a new fluorine DAT tracer, the 18F-LBT-999, J Nucl Med, vol.58, p.413, 2017. ,
Correlation of 99mTc-TRODAT-1 SPECT imaging findings and clinical staging of Parkinson's disease, Clin Nucl Med, vol.44, pp.347-50, 2019. ,
Dopamine transporter imaging with [ 18 F]FE-PE2I PET and [ 123 I]FP-CIT SPECT-a clinical comparison, EJNMMI Res, vol.8, p.100, 2018. ,